- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01602536
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Smoking relapse rates remain high, innovative strategies are needed to lower them, and web-based social networking may help like Twitter. This developmental research examined whether providing virtual (web-based) social support to smokers, through Twitter-enabled interactive peer texting, could help smokers quit and avoid relapses. Twitter is a free social networking and micro-blogging service, one of the most advanced and novel technologies available today that can provide social support to smokers, and it provides free texting to groups. It is global and has many features that are associated with treatment success including interactive, multi-way, live messaging and mobile accessibility, because the messages go instantly to mobile phones and to the web. It can provide an innovative way to reach smokers who might otherwise not seek treatment, and it can be extended to other health domains.
In Phase II which took place from June 2012 through 2013, we conducted a two-condition randomized controlled trial (Aim 2). All participants in this trial (N=160) received 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov Quit Guide, and instruction to set a quit date within 1 week of study start. Participants were also randomly assigned at the individual level to one of two conditions: (1) a virtual quit-smoking Twitter group condition where the group members were instructed to use Twitter-enabled interactive peer messaging to help them quit and stay quit, or (2) a control group condition where the group members were not given this instruction or a Twitter group. In total, there were 4 Twitter groups and 4 control groups with 20 smokers randomly assigned to each group (i.e., N=80 test, N=80 control). The primary outcome was self-reported 7-day point prevalence abstinence that was sustained at 7, 30 and 60 days after the quit date. Participants' tweets, their virtual and face-to-face social networks, and several other possible mediating and moderating variables were also analyzed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 92697
- University of California Irvine
-
Irvine, California, United States, 92697
- Hosted Study Website Tweet2Quit@Merage.Uci.Edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- must have smoked 100 cigarettes during their lifetime
- must currently smoke 5 or more cigarettes a day
- must be in the preparation stage of quitting smoking
- ages 18-59 years
- English speaking
- have a mobile phone with an unlimited texting plan and internet access
- use text messaging at least once a week
- use Facebook daily
- have an active email account
- live in the continental USA
Exclusion Criteria:
- a medical condition that is contra-indicated for nicotine replacement therapy:
- pregnant
- breast feeding
- a recent heart attack
- an irregular heartbeat
- high blood pressure not controlled with medication
- skin allergies to adhesive tape or serious skin problems
- taking a prescription medicine for depression or anxiety
- use drugs or marijuana regularly
- live in the same household with another participant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Twitter
Experimental participants are assigned a 20-person twitter quit-smoking group to interact with, are instructed to use Twitter-enabled interactive peer messaging,and are sent daily messages to encourage interaction.
The baseline intervention 'smoking cessation aides' is also provided.
|
All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov
Quit Guide, and instruction to set a quit date within 8 days of study start.
Twitter quit-smoking group
|
Active Comparator: Control
Control participants are not assigned to a twitter group.
The baseline intervention 'smoking cessation aides' is also provided.
|
All participants will receive 8 weeks of free nicotine patches, referral to the NCI's online Smokefree.gov
Quit Guide, and instruction to set a quit date within 8 days of study start.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
self-reported 7-day point prevalence abstinence from smoking that was sustained at 7, 30 and 60 days after the quit date
Time Frame: 60 days after quit date
|
60 days after quit date
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
level of engagement based on tweet volume
Time Frame: 100 days total
|
100 days total
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cornelia Pechmann, PhD, University of California, Irvine
Publications and helpful links
General Publications
- Pechmann C, Delucchi K, Lakon CM, Prochaska JJ. Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention. Tob Control. 2017 Mar;26(2):188-194. doi: 10.1136/tobaccocontrol-2015-052768. Epub 2016 Feb 29.
- Pechmann C, Pan L, Delucchi K, Lakon CM, Prochaska JJ. Development of a Twitter-based intervention for smoking cessation that encourages high-quality social media interactions via automessages. J Med Internet Res. 2015 Feb 23;17(2):e50. doi: 10.2196/jmir.3772.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R34DA030538-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityRecruitingSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on smoking cessation aides
-
Oregon Research Behavioral Intervention Strategies...RecruitingTobacco UseUnited States
-
The University of Hong KongCompletedSmoking CessationHong Kong
-
Washington University School of MedicineCompleted
-
University of Missouri, Kansas CityCompleted
-
The University of Hong KongNot yet recruiting
-
ImbioNational Cancer Institute (NCI); Mayo Clinic; University of Michigan; University... and other collaboratorsCompleted
-
Oulu University HospitalActive, not recruiting
-
Kimber Richter, PhD, MPH, MANational Heart, Lung, and Blood Institute (NHLBI)CompletedSmokingUnited States
-
University of Wisconsin, MadisonCompletedSmoking | Tobacco Use DisorderUnited States
-
London South Bank UniversityNHS Lambeth; NHS Southwark CCG; Allen Carr EasywayCompleted